Chemycal has been acquired by 3E

Learn More

Pharmaceutical Strategy - Timely patient access to affordable medicines | Consultation period 02 June 2020 - 07 July 2020


Your substances

None


The strategy aims to ensure Europe’s supply of safe and affordable medicines to meet patients’ needs and support the European pharmaceutical industry’s innovation efforts. It will address all levels of the value chain from research and development to authorisation and access of patients to medicines taking into account scientific and technological advances. Lessons learned from the COVID-19 pandemic around preparedness and supply chains will also be addressed.

CONTINUE READING ON: ec.europa.eu

                   

Related News

Loading...